As a result of new laboratory data, the biotech company is deemphasizing more complex “multivalent” booster shots in favor of further study of its existing formulation and an omicron-specific version.
The two sides reached an agreement after two weeks of discussions with federal mediators, including a final in-person session mediated by U.S. Secretary of Labor Marty Walsh.
The deal further pushes Oracle into the healthcare market, where its presence is mostly in data use efficiency for payers and providers. Oracle’s areas of focus include database software and cloud systems.
The bugs in Apache’s Java-based open source logging library could potentially allow unauthorized users to remotely impact the safety and effectiveness of device functionality, according to the agency.
Cleveland Clinic, Banner Health and other hospital systems are pausing nonessential procedures, while provider groups issued a joint statement Friday declaring that doctors and nurses are exhausted and heartbroken.
In the face of a national crisis, now is the time to invest in attracting and retaining great talent for patient care.
Days after the FDA strengthened safety warnings for the company’s shot, a CDC panel recommended Pfizer’s and Moderna’s vaccines be “preferred” over J&J’s.
Over 73% of physicians reported feeling overworked amid the pandemic and 50% said they are considering an employment change because of it, Doximity’s annual report found.
While the emergence of the omicron variant is muddying next year’s medtech outlook, analysts have identified three niches within the sector best positioned to successfully weather the continued strains on the healthcare system.
Diagnostics from Applied DNA Sciences, Meridian Bioscience and Tide Laboratories are not able to detect omicron, causing false negative results, and should not be used, the agency said.